| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
Factor X (Coagulation)FondaparinuxCoronary heart disease (BASKET)| 1 | 2002 | Fondaparinux, a synthetic pentasaccharide: the first in a new class of antithrombotic agents - the selective factor Xa inhibitors. | 
| + | - | nl | Cardiovasc Drug Rev 20(1):37-52 (2002) |
| 2 | 2010 | Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies. | 
| + | - | nl | Vasc Health Risk Manag 6(-):179-87 (2010) |
| 3 | 2007 | Management of acute coronary syndromes with fondaparinux. | 
| + | - | nl | Vasc Health Risk Manag 3(3):321-9 (2007) |
| 4 | 2006 | Fondaparinux in the management of patients with ST-elevation acute myocardial infarction. | 
| + | - | nl | Vasc Health Risk Manag 2(4):371-8 (2006) |
| 5 | 2006 | Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery. | 
| + | - | nl | Vasc Health Risk Manag 2(4):365-70 (2006) |